| ZAKLUA ASTELLAS PHARMA INC.
2197849 16 May 2022 | on 12 Feb 2024 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for the treatment of cancer. | | | ZAKLARIS ASTRAZENECA AB
1399390 12 Jun 2008 | on 06 Jul 2011 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the metabolism; pharmaceutical preparations and substances for the prevention and treatment of diseases and disorders of the respiratory system; pharmaceutical preparations and substances for the prevention and treatment of diseases and disorders of the central nervous system, namely central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders and spinal cord diseases; pharmaceutical preparations and substances for the prevention and treatment of diseases and disorders of the peripheral nervous system, namely peripheral nervous system infections, cranial and spinal nerve diseases and peripheral system movement disorders; pharmaceutical preparations for the treatment of gynaecological diseases and disorders, namely sexually transmitted diseases, infertility, hormone replacement therapy preparations, contraceptives, inflammatory pelvic diseases, urological diseases and infertility; pharmaceutical preparations and substances for the prevention and treatment of diseases and disorders of the cardiovascular system; pharmaceutical preparations and substances for the treatment of diseases and disorders of the gastro-intestinal system; pharmaceutical preparations and substances for use in pain control, arthritis, anaesthesia, oncology, urology and diabetes; pharmaceutical preparations and substances for the prevention and treatment of inflammatory diseases, namely inflammatory bowel diseases and inflammatory connective tissue diseases; anti-infectives. | | 
